| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Author Index
|
|
|
2013
|
106 |
S1 |
p. S58-S62
5 p.
|
artikel
|
| 2 |
Copyright
|
|
|
2013
|
106 |
S1 |
p. iv-
1 p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
2013
|
106 |
S1 |
p. v-
1 p.
|
artikel
|
| 4 |
Information for Authors
|
|
|
2013
|
106 |
S1 |
p. ii-
1 p.
|
artikel
|
| 5 |
OC-018: De-Intensification Candidate Subgroups in HPV(+) Oropharyngeal Cancer Based on Minimal Risk of Distant Metastasis
|
O'Sullivan, B.
|
|
2013
|
106 |
S1 |
p. S6-
1 p.
|
artikel
|
| 6 |
OC-021: Failure-Probability Driven Dose Painting
|
Vogelius, I.R.
|
|
2013
|
106 |
S1 |
p. S7-S8
2 p.
|
artikel
|
| 7 |
OC-037: mTHPC Mediated Interstitial Photodynamic Therapy of Recurrent Head and Neck Cancer: Development of a New Method
|
Karakullukcu, B.
|
|
2013
|
106 |
S1 |
p. S15-
1 p.
|
artikel
|
| 8 |
OC-038: Node Stage/Extracapsular Spread Predict Contralateral Node Failure After Unilateral Irradiation of Tonsil Cancer
|
Lynch, J.
|
|
2013
|
106 |
S1 |
p. S15-S16
2 p.
|
artikel
|
| 9 |
OC-020: Non Invasive PET Imaging of Cetuximab-Zirconium-89 Biodistribution: A Phase i Trial
|
Van Loon, J.
|
|
2013
|
106 |
S1 |
p. S7-
1 p.
|
artikel
|
| 10 |
OC-019: Preclinical Rationale for Combining the Smac-Mimetic Debio 1143 with Concurrent Chemio-Radiotherapy In La-SCCHN
|
Viertl, D.
|
|
2013
|
106 |
S1 |
p. S6-S7
2 p.
|
artikel
|
| 11 |
OC-036: Resistance Training and Dietary Supplements in Radiotherapy Treated Head and Neck Cancer Patients (DAHANCA 25A)
|
Lønbro, S.
|
|
2013
|
106 |
S1 |
p. S14-S15
2 p.
|
artikel
|
| 12 |
OC-039: Surveillance of Head and Neck Cancer (HNC) Patients: Clinical and Radiological Exams or Symptom Driven Follow Up?
|
Imbimbo, M.
|
|
2013
|
106 |
S1 |
p. S16-
1 p.
|
artikel
|
| 13 |
OC-017: Temporal Regression and Regional Control Following Primary Radiotherapy for HPV(+) vs. HPV(-) Head & Neck Cancers
|
Huang, S.H.
|
|
2013
|
106 |
S1 |
p. S5-S6
2 p.
|
artikel
|
| 14 |
PD-025: Adding MR-Images to CT-Based GTV Delineation in Laryngeal Carcinoma: Effect On Interobserver Agreement
|
Jager, E.A.
|
|
2013
|
106 |
S1 |
p. S9-S10
2 p.
|
artikel
|
| 15 |
PD-022: Clinical Evaluation of an Adaptive Radiotherapy Software on a Head and Neck Cancer Population
|
Mahjoubi, K.
|
|
2013
|
106 |
S1 |
p. S8-
1 p.
|
artikel
|
| 16 |
PD-041: Does Ipsilateral Radiotherapy Offer Acceptable Locoregional Control in SCC of Unknown Primary in the PET-CT era?
|
Daly, P.E.
|
|
2013
|
106 |
S1 |
p. S17-
1 p.
|
artikel
|
| 17 |
PD-027: FAZA PET/CT Hypoxia Imaging in Patients with HNSCC Treated with Radiotherapy: Results from the Dahanca 24 Trial
|
Mortensen, L.S.
|
|
2013
|
106 |
S1 |
p. S11-
1 p.
|
artikel
|
| 18 |
PD-045: HPV Specific T-Cell Responses and Immune Status Before and After Radiotherapy in Patients with Oropharyngeal Cancer
|
Banner, R.
|
|
2013
|
106 |
S1 |
p. S18-S19
2 p.
|
artikel
|
| 19 |
PD-026: Hypoxia Imaging with [18F] HX4 PET in HNSCC: Defining Optimal Imaging Timepoint for Monitoring Response
|
Zegers, C.M.L.
|
|
2013
|
106 |
S1 |
p. S10-S11
2 p.
|
artikel
|
| 20 |
PD-042: Impact of Comorbidities in Charlson Comorbidity Index in 9,389 HNSCC Patients: Study from the Dahanca Database
|
Boeje, C.
|
|
2013
|
106 |
S1 |
p. S17-
1 p.
|
artikel
|
| 21 |
PD-029: Laryngeal and Hypopharyngeal Carcinoma: Correlation Between Diffusion Weighted MRI and Tissue Components
|
Driessen, J.P.
|
|
2013
|
106 |
S1 |
p. S12-
1 p.
|
artikel
|
| 22 |
PD-023: Prediction of Early Response to Radiation Therapy Using FDG-PET Standard Uptake Value
|
Hernandez, O.
|
|
2013
|
106 |
S1 |
p. S8-S9
2 p.
|
artikel
|
| 23 |
PD-043: Randomized Comparison of Acute Toxicities in HNSCC Receiving Concurrent CHEMO-RT vs Accelerated Fractionation RT
|
Das, S.
|
|
2013
|
106 |
S1 |
p. S17-S18
2 p.
|
artikel
|
| 24 |
PD-028: Suvmax and Gross Tumor Volume Associated with Failure After (Chemo-) Radiotherapy for HNSCC
|
Rasmussen, J.
|
|
2013
|
106 |
S1 |
p. S11-S12
2 p.
|
artikel
|
| 25 |
PD-024: The use of Sequential Diffusion Weighted MRI in the Early Prediction of Volumetric Changes During Radiotherapy
|
Nevens, D.
|
|
2013
|
106 |
S1 |
p. S9-
1 p.
|
artikel
|
| 26 |
PD-040: The Weakest Link …. Medical Physicists Need Dedicated Software and Further Training for Rotational IMRT
|
De Hertogh, O.
|
|
2013
|
106 |
S1 |
p. S16-
1 p.
|
artikel
|
| 27 |
PD-044: Weekly Versus Three Weekly Cisplatin in Postoperative Chemoradiotherapy for High Risk Head and Neck Cancer
|
Jovanovic Korda, N.
|
|
2013
|
106 |
S1 |
p. S18-
1 p.
|
artikel
|
| 28 |
PO-113: Activity and Safety of Vinorelbine in Adenoid Cystic Carcinoma: A Single Institution Retrospective Case Series
|
Locati, L.
|
|
2013
|
106 |
S1 |
p. S47-S48
2 p.
|
artikel
|
| 29 |
PO-088: Acute Toxicity in Head and Neck Cancer Patients Treated with Chemoradiation/Cetuximab ± Consolidation Cetuximab
|
Riesterer, O.
|
|
2013
|
106 |
S1 |
p. S37-
1 p.
|
artikel
|
| 30 |
PO-126: Adaptive Radiation Therapy in HPV Positive Oropharyngeal Carcinoma: A Preliminary Toxicity Report
|
Alizadeh, M.
|
|
2013
|
106 |
S1 |
p. S54-
1 p.
|
artikel
|
| 31 |
PO-109: Age-Related Differences in Guideline Adherence for Head and Neck Cancer
|
Uppelschoten, J.
|
|
2013
|
106 |
S1 |
p. S46-
1 p.
|
artikel
|
| 32 |
PO-053: Analytical Study to See Effect of Nandrolone Decanoate in PTS. Of Advanced Stage CA H&N Undergoing Therapy (RT/CRT)
|
Kumar, D.
|
|
2013
|
106 |
S1 |
p. S22-
1 p.
|
artikel
|
| 33 |
PO-058: An Exploration of Factors Predicting Malnutrition in Patients with Advanced Head and Neck Cancer
|
Hammerlid, E.
|
|
2013
|
106 |
S1 |
p. S24-
1 p.
|
artikel
|
| 34 |
PO-065: A Simple ARC Technique for Prophylactic Cranial Irradiation Greatly Reduces the Radiation Dose to the Parotid Glands
|
Granzier, M.E.P.G.
|
|
2013
|
106 |
S1 |
p. S27-
1 p.
|
artikel
|
| 35 |
PO-083: Breakthrough Pain in Head and Neck Cancer Patients Undergoing Radiotherapy. Treatment with Nasal Fentanyl.
|
Prieto, I.
|
|
2013
|
106 |
S1 |
p. S35-
1 p.
|
artikel
|
| 36 |
PO-080: Cetuximab (CTX) in Recurrent and Metastatic Head and Neck Squamous-Cell Carcinoma (HN SCC) ñ Our Extreme Experience
|
Gouveia, E.
|
|
2013
|
106 |
S1 |
p. S34-
1 p.
|
artikel
|
| 37 |
PO-078: Cetuximab Plus Chemotherapy for Asian Patients with Recurrent and/or Metastatic Head and Neck Cancer
|
Guo, Y.
|
|
2013
|
106 |
S1 |
p. S33-
1 p.
|
artikel
|
| 38 |
PO-077: Cetuximab Plus Radiotherapy for Chinese Patients with Locally Advanced Head and Neck Cancer
|
Gao, L.
|
|
2013
|
106 |
S1 |
p. S32-S33
2 p.
|
artikel
|
| 39 |
PO-110: Chemo-Radiotherapy for Locally Advanced Head and Neck Cancer in the Elderly Population: A Unicentric Experience
|
Bahig, H.
|
|
2013
|
106 |
S1 |
p. S46-S47
2 p.
|
artikel
|
| 40 |
PO-062: Cisplatin and 5-FU Induction Chemotherapy Followed By Chemoradiotherapy in Advanced Nasopharyngeal Carcinoma
|
Bouzguenda, R.
|
|
2013
|
106 |
S1 |
p. S25-S26
2 p.
|
artikel
|
| 41 |
PO-115: Cisplatin Plus Capecitabine Chemotherapy for Recurrent or Metastatic Head and Neck Squamous Cell Cancer
|
McPartlin, A.J.
|
|
2013
|
106 |
S1 |
p. S48-S49
2 p.
|
artikel
|
| 42 |
PO-076: Combined Reirradiation and Cetuximab for Locally Recurrent Head and Neck Cancer ñ Mature Overal Survival Results
|
Milanovic, D.
|
|
2013
|
106 |
S1 |
p. S32-
1 p.
|
artikel
|
| 43 |
PO-061: Concurrent Cisplatin-Radiotherapy with or Without TPF Induction Chemotherapy in Nasopharyngeal Carcinoma
|
Toumi, N.
|
|
2013
|
106 |
S1 |
p. S25-
1 p.
|
artikel
|
| 44 |
PO-105: Critical Weight Loss Before and During (Adjuvant) Radiotherapy: Major Prognostic Factors for Survival
|
Eerenstein, S.E.J.
|
|
2013
|
106 |
S1 |
p. S44-S45
2 p.
|
artikel
|
| 45 |
PO-055: Definitive Radiotherapy for Larynx Cancer: Impact of Local Relapse on Outcome and Implications for Salvage Surgery
|
Hoebers, F.
|
|
2013
|
106 |
S1 |
p. S22-S23
2 p.
|
artikel
|
| 46 |
PO-087: Delayed Oral Mucosa Injury After Radiotherapy for Head and Neck Cancer Assessed By Exfoliative Oral Cytology
|
Massaro, P.
|
|
2013
|
106 |
S1 |
p. S37-
1 p.
|
artikel
|
| 47 |
PO-112: Early and Late Complications in Conservative Laryngeal Surgery
|
Deganello, A.
|
|
2013
|
106 |
S1 |
p. S47-
1 p.
|
artikel
|
| 48 |
PO-056: Early-Outcome and Toxicity of RT/CT in the Management of Unknown HN Primary Site with Helical Tomotherapy
|
Belgioia, L.
|
|
2013
|
106 |
S1 |
p. S23-
1 p.
|
artikel
|
| 49 |
PO-111: Effect of Body Mass Index and Hemoglobin Level on Chemoradiation Outcomes in Head and Neck Cancer
|
Loi, M.
|
|
2013
|
106 |
S1 |
p. S47-
1 p.
|
artikel
|
| 50 |
PO-133: Endoscopy Guided Brachytherapy (EGBT) for Sinonasal and Nasopharyngeal Recurrences
|
Tagliaferri, L.
|
|
2013
|
106 |
S1 |
p. S57-
1 p.
|
artikel
|
| 51 |
PO-098: Epstein-Barr Virus Latent Membrane Protein Type 1 (LMP1) Expression in Non Endemic Nasopharyngeal Carcinoma
|
Rosales-Pérez, S.
|
|
2013
|
106 |
S1 |
p. S41-S42
2 p.
|
artikel
|
| 52 |
PO-064: Establishing an Intranet Based Platform to Improve the Multidisciplinary Management of Head and Neck Patients
|
Specht, H.M.
|
|
2013
|
106 |
S1 |
p. S26-S27
2 p.
|
artikel
|
| 53 |
PO-069: Feasibility of Dose Painting to a Five Level Dose Prescription iñ a Dose Planning Study
|
Håkansson, K.
|
|
2013
|
106 |
S1 |
p. S29-
1 p.
|
artikel
|
| 54 |
PO-114: Feasibility Study of the Next Generation Provox Voice Prosthesis Vega: The Smart Inserter Insertion System
|
Margolin, G.
|
|
2013
|
106 |
S1 |
p. S48-
1 p.
|
artikel
|
| 55 |
PO-086: Feeding Tube Dependence in Patients with Oropharyngeal Cancer Treated with 3D Conformal Radiotherapy Versus IMRT.
|
Benghiat, H.
|
|
2013
|
106 |
S1 |
p. S36-S37
2 p.
|
artikel
|
| 56 |
PO-066: High-Dose Reirradiation for Recurrent Head-and-Neck Cancer with IMRT: Long-Term Survival and Severe Toxicity.
|
Duprez, F.
|
|
2013
|
106 |
S1 |
p. S27-S28
2 p.
|
artikel
|
| 57 |
PO-124: HPV DNA in Pharyngeal Swabs as a Marker of Hpvdependent Squamous Cell Cancer of the Oropharynx.
|
Rutkowski, T.W.
|
|
2013
|
106 |
S1 |
p. S52-S53
2 p.
|
artikel
|
| 58 |
PO-128: HPV Infection in Head and Neck Cancer. Is P16 Immunohistochemistry a Reliable Surrogate Marker?
|
Bussu, F.
|
|
2013
|
106 |
S1 |
p. S54-S55
2 p.
|
artikel
|
| 59 |
PO-120: HPV/P16 Status: A Factor to Consider in Organ Preservation for Locally Advanced Laryngeal & Hypopharyngeal Cancer?
|
Shaughnessy, J.
|
|
2013
|
106 |
S1 |
p. S51-
1 p.
|
artikel
|
| 60 |
PO-121: Human Papilloma Virus Infection in Oral and Oropharyngeal Cancer; are They the Same?
|
Pongsapich, W.
|
|
2013
|
106 |
S1 |
p. S51-S52
2 p.
|
artikel
|
| 61 |
PO-100: Identification of Head and Neck Carcinoma Cell Lines with a Mesenchymal Phenotype.
|
Téllez-Gabriel, M.
|
|
2013
|
106 |
S1 |
p. S42-S43
2 p.
|
artikel
|
| 62 |
PO-119: IMRT for Oropharyngeal Carcinoma: Preliminary Results Focusing on the Impact of HPV Status and Risk Categories
|
Orlandi, E.
|
|
2013
|
106 |
S1 |
p. S50-S51
2 p.
|
artikel
|
| 63 |
PO-118: Incidence and Prognosis of HPV Induced Oropharyngeal Cancer in a Cohort of Patients Treated with Chemoradiation
|
Cerezo, L.
|
|
2013
|
106 |
S1 |
p. S50-
1 p.
|
artikel
|
| 64 |
PO-132: Intensity Modulated Radiation Therapy in Sinonasal Sarcoma: Dosimetry and Clinical Outcome
|
Biswas, A.
|
|
2013
|
106 |
S1 |
p. S56-
1 p.
|
artikel
|
| 65 |
PO-123: Is Radiation with Cetuximab an Effective Treatment in HPV Positive Head and Neck Squamous Cell Cancer?
|
Ye, A.
|
|
2013
|
106 |
S1 |
p. S52-
1 p.
|
artikel
|
| 66 |
PO-081: Late Toxicity After Radical Treatment for Locally Advanced Head-and-Neck Carcinomas.
|
Taberna, M.
|
|
2013
|
106 |
S1 |
p. S34-S35
2 p.
|
artikel
|
| 67 |
PO-084: Locally Advanced Head and Neck Cancer Treated with Accelerated Radiotherapy, Nimorazol and Weekly Cisplatinum.
|
Bentzen, J.
|
|
2013
|
106 |
S1 |
p. S35-S36
2 p.
|
artikel
|
| 68 |
PO-073: Low Dose Fractionated Radiotherapy in Association to Induction Chemotherapy in Locally Advanced H&N Cancer
|
Dinapoli, N.
|
|
2013
|
106 |
S1 |
p. S31-
1 p.
|
artikel
|
| 69 |
PO-097: Margin for Clinical Target Volume (CTV) in Laryngeal and Hypopharyngeal Cancer: A Histological Study
|
Caldas-Magalhaes, J.
|
|
2013
|
106 |
S1 |
p. S41-
1 p.
|
artikel
|
| 70 |
PO-091: NG Tubes or Prophylactic Gastrostomies? - Impact on Long Term Swallowing Function Following Chemoradiotherapy
|
Prestwich, R.
|
|
2013
|
106 |
S1 |
p. S38-S39
2 p.
|
artikel
|
| 71 |
PO-129: Optimizing Radiosensitization with Metabolic Imaging in Anaplastic Thyroid Cancer
|
Sandulache, V.C.
|
|
2013
|
106 |
S1 |
p. S55-
1 p.
|
artikel
|
| 72 |
PO-108: Oral Microbiota Analysis of Serial Sequencing 16S RRNA in Oropharyngeal Cancer Patients During Radiotherapy
|
Choi, Y.
|
|
2013
|
106 |
S1 |
p. S45-S46
2 p.
|
artikel
|
| 73 |
PO-067: Phase II Study: CT-Guided Interstitial 60 Co-HDR-Brachytherapy with MRI Fusion for Boost Head AND Neck Patient
|
Lozhkov, A.
|
|
2013
|
106 |
S1 |
p. S28-
1 p.
|
artikel
|
| 74 |
PO-054: Postoperative Concurrent Cisplatin Based Chemoradiation in High Risk Squamous Cell Carcinoma of Oral Cavity
|
Bandyopadhyay, A.
|
|
2013
|
106 |
S1 |
p. S22-
1 p.
|
artikel
|
| 75 |
PO-125: Primary Radiation-Based Management of Oropharyngeal Cancer: A Comprehensive 20-Year Single Institution Review
|
Mohindra, P.
|
|
2013
|
106 |
S1 |
p. S53-S54
2 p.
|
artikel
|
| 76 |
PO-101: Prognostic Role of MMP-9 Expression in H&N Carcinoma Patients Treated with Radiotherapy or Chemoradiotherapy
|
Garcia Lorenzo, J.
|
|
2013
|
106 |
S1 |
p. S43-
1 p.
|
artikel
|
| 77 |
PO-102: Prognostic Value of Osteopontin and C-Reactive Protein for Patients with Head and Neck Cancer.
|
Mrochem-Kwarciak, J.
|
|
2013
|
106 |
S1 |
p. S43-
1 p.
|
artikel
|
| 78 |
PO-116: Prophylactic Swallowing Exercises on Dysphagia After Radiotherapy iñ a Randomised Trial.
|
Mortensen, H.R.
|
|
2013
|
106 |
S1 |
p. S49-
1 p.
|
artikel
|
| 79 |
PO-131: Radiotherapy for Unresectable Sinonasal Cancer: IMRT vs Coplanar and Non-Coplanar VMAT
|
Giandini, T.
|
|
2013
|
106 |
S1 |
p. S56-
1 p.
|
artikel
|
| 80 |
PO-104: Randomised Trial on the Treatment of Pain in HNSCC: Is Methadone Superior to Fentanyl? Results of an Interim Analysis.
|
van den Beuken-van Everdingen, M.
|
|
2013
|
106 |
S1 |
p. S44-
1 p.
|
artikel
|
| 81 |
PO-079: Review of Cetuximab Versus Cisplatin Concurrent with Radiotherapy in Lahnscc: A Single Institution Experience
|
Cagney, D.
|
|
2013
|
106 |
S1 |
p. S33-S34
2 p.
|
artikel
|
| 82 |
PO-063: Role of Concurrent Low Dose Cisplatin with Radiation in Locally Advanced H&N Cancer.
|
Gupta, L.
|
|
2013
|
106 |
S1 |
p. S26-
1 p.
|
artikel
|
| 83 |
PO-107: Role of Honey in Prevention of Radiation Induced Mucositis in Head and Neck Cancer
|
Alvi, Z.
|
|
2013
|
106 |
S1 |
p. S45-
1 p.
|
artikel
|
| 84 |
PO-071: Role of Intensity Modulated Radiotherapy in Head and Neck Cancers: A Tertiary Cancer Center Experience.
|
Behera, M.
|
|
2013
|
106 |
S1 |
p. S30-
1 p.
|
artikel
|
| 85 |
PO-103: Role of Karnowsky Index in the Management of Undifferentiated Nasopharyngeal Carcinoma of the Adult
|
Atif, F.
|
|
2013
|
106 |
S1 |
p. S43-S44
2 p.
|
artikel
|
| 86 |
PO-106: Safety and Effectiveness of Prolonged Nasogastric Tube for Head and Neck Cancer Undergoing Radiotherapy.
|
Espeli, V.
|
|
2013
|
106 |
S1 |
p. S45-
1 p.
|
artikel
|
| 87 |
PO-092: Salivary Cytokine Levels and Mucositis in Head and Neck Cancer Patients Treated with Chemoradiotherapy.
|
Bossi, P.
|
|
2013
|
106 |
S1 |
p. S39-
1 p.
|
artikel
|
| 88 |
PO-057: SIB-IMRT Delivered By Helical Tomotherapy for Patients with Nasopharyngeal Carcinoma
|
Bacigalupo, A.
|
|
2013
|
106 |
S1 |
p. S23-S24
2 p.
|
artikel
|
| 89 |
PO-068: Simultaneous Integrated Boost-Intensity Modulated Radiotherapy (SIB-IMRT) in the Treatment of H&N Cancer
|
Bonomo, P.
|
|
2013
|
106 |
S1 |
p. S28-S29
2 p.
|
artikel
|
| 90 |
PO-090: Smaller Margins Do Matter in Radiotherapy for Laryngeal Cancer
|
Terhaard, C.
|
|
2013
|
106 |
S1 |
p. S38-
1 p.
|
artikel
|
| 91 |
PO-082: Sparing the Contralateral Submandibular Gland in Oropharyngeal Cancer Patients: Initial Experience.
|
Dijkema, T.
|
|
2013
|
106 |
S1 |
p. S35-
1 p.
|
artikel
|
| 92 |
PO-072: Subtotal Laryngectomy: New Surgical Devices Influence Techniques and Functional Results.
|
Mannelli, G.
|
|
2013
|
106 |
S1 |
p. S30-S31
2 p.
|
artikel
|
| 93 |
PO-117: Symptom Burden and Quality of Life Analysis in Head and Neck Cancer Patients Suitable for Palliative Radiotherapy
|
Gandhi, A.K.
|
|
2013
|
106 |
S1 |
p. S49-S50
2 p.
|
artikel
|
| 94 |
PO-060: The Effect of Induction Chemotherapy on Tumor Volume and Organ Sparing in Locally Advanced Oropharyngeal Cancer
|
Doornaert, P.
|
|
2013
|
106 |
S1 |
p. S25-
1 p.
|
artikel
|
| 95 |
PO-075: The Extreme Regimen for Recurrent/Metastatic HNSCC: Treatment Outcome in a Single Institution Cohort
|
Lynggaard, C.D.
|
|
2013
|
106 |
S1 |
p. S31-S32
2 p.
|
artikel
|
| 96 |
PO-094: The Impact of Toxicity During Radiochemotherapy with Cetuximab or Cisplatin in Oropharyngeal Cancer
|
Autorino, R.
|
|
2013
|
106 |
S1 |
p. S39-S40
2 p.
|
artikel
|
| 97 |
PO-099: The Prognostic Importance of Molecular-Genetics and Morphological Factors in Prognosis of Recurrent HNSCC
|
Kutukova, S.I.
|
|
2013
|
106 |
S1 |
p. S42-
1 p.
|
artikel
|
| 98 |
PO-122: The Prognostic Role of Epidemiological Factors in Prognosis of Recurrent HNSCC
|
Kutukova, S.
|
|
2013
|
106 |
S1 |
p. S52-
1 p.
|
artikel
|
| 99 |
PO-096: Therapeutic and Prognostic Impact Value of FDG PET/CT in Newly Diagnosed Head and Neck Malignancy
|
De Juan Rubio, R.
|
|
2013
|
106 |
S1 |
p. S41-
1 p.
|
artikel
|
| 100 |
PO-130: The Role of Irradiation in Differentiated Thyroid Carcinomas
|
Sun, X.S.
|
|
2013
|
106 |
S1 |
p. S55-
1 p.
|
artikel
|
| 101 |
PO-127: The Role of P16 in the Radiation Sensitivity of Hpvpositive Head and Neck Cancers
|
Nuyts, S.
|
|
2013
|
106 |
S1 |
p. S54-
1 p.
|
artikel
|
| 102 |
PO-059: The Role of Tumour Markers and Clinico-Laboratories Result in Prognosis of Relapse Oral Squamous Cell Carcinoma
|
Kutukova, S.I.
|
|
2013
|
106 |
S1 |
p. S24-S25
2 p.
|
artikel
|
| 103 |
PO-089: The Self-Care Rehabilitation in the Patients with Head and Neck Cancer Treated with Definitive Radiotherapy
|
Yurut-Caloglu, V.
|
|
2013
|
106 |
S1 |
p. S37-S38
2 p.
|
artikel
|
| 104 |
PO-093: The Tolerance of TPF Followed By RTC in Advanced H&N Cancer Patients - Single-Institution Retrospective Analysis
|
Sierko, E.
|
|
2013
|
106 |
S1 |
p. S39-
1 p.
|
artikel
|
| 105 |
PO-085: Tongue Cancer After Radiotherapy for Nasopharyngeal Carcinoma. Three Cases Report and Literature Review
|
Mnejja, W.
|
|
2013
|
106 |
S1 |
p. S36-
1 p.
|
artikel
|
| 106 |
PO-070: Treatment of Head and Neck Cancers: Preliminary Experience with Helical Tomotherapy.
|
Garibaldi, E.
|
|
2013
|
106 |
S1 |
p. S29-S30
2 p.
|
artikel
|
| 107 |
PO-074: Utilisation of Tc99m-Tilmanocept to Assess Sentinel Lymph Node Status in HNSCC Patients
|
Lai, S.Y.
|
|
2013
|
106 |
S1 |
p. S31-
1 p.
|
artikel
|
| 108 |
PO-095: Validating a Dysphagia Predictor in Head and Neck Cancer Patients Treated with VMAT
|
Duffton, A.
|
|
2013
|
106 |
S1 |
p. S40-
1 p.
|
artikel
|
| 109 |
SP-047: Against the Motion
|
Jones, T.M.
|
|
2013
|
106 |
S1 |
p. S19-S20
2 p.
|
artikel
|
| 110 |
SP-052: Against the Motion
|
Harari, P.
|
|
2013
|
106 |
S1 |
p. S21-
1 p.
|
artikel
|
| 111 |
SP-032: Biomarkers of Proliferation and Hypoxia; How Well can They Predict Response to Arcon?
|
Kaanders, J.H.
|
|
2013
|
106 |
S1 |
p. S12-S13
2 p.
|
artikel
|
| 112 |
SP-008: Concert Randomised Trials with Panitumumab
|
Giralt, J.
|
|
2013
|
106 |
S1 |
p. S3-
1 p.
|
artikel
|
| 113 |
SP-035: Five-Year Results of the ARTSCAN Randomised Trial on Accelerated Radiotherapy
|
Zackrisson, B.
|
|
2013
|
106 |
S1 |
p. S13-S14
2 p.
|
artikel
|
| 114 |
SP-046: FOR the Motion
|
Simon, C.
|
|
2013
|
106 |
S1 |
p. S19-
1 p.
|
artikel
|
| 115 |
SP-051: For the Motion
|
Merlano, M.
|
|
2013
|
106 |
S1 |
p. S20-S21
2 p.
|
artikel
|
| 116 |
SP-015: Functional Imaging for Selecting and Monitoring Treatments
|
Grégoire, V.
|
|
2013
|
106 |
S1 |
p. S5-
1 p.
|
artikel
|
| 117 |
SP-030: GORTEC 99-02 Randomised Trial
|
Bourhis, J.
|
|
2013
|
106 |
S1 |
p. S12-
1 p.
|
artikel
|
| 118 |
SP-013: How do we Predict Chemo-Radio Sensitivity?
|
Cohen, E.
|
|
2013
|
106 |
S1 |
p. S4-
1 p.
|
artikel
|
| 119 |
SP-014: How to Detect and Use HPV Status?
|
Brakenhoff, R.H.
|
|
2013
|
106 |
S1 |
p. S4-S5
2 p.
|
artikel
|
| 120 |
SP-002: HPV
|
Castellsagué, X.
|
|
2013
|
106 |
S1 |
p. S1-
1 p.
|
artikel
|
| 121 |
SP-004: Long Term Results of Intergroup RTOG 91-11: A Comparison of Three Treatments to Preserve the Larynx
|
Forastière, A.
|
|
2013
|
106 |
S1 |
p. S1-S2
2 p.
|
artikel
|
| 122 |
SP-001: New Insights into the Epidemiology of Head and Neck Cancers
|
Gatta, G.
|
|
2013
|
106 |
S1 |
p. S1-
1 p.
|
artikel
|
| 123 |
SP-016: New Markers of Metastases
|
Erler, J.T.
|
|
2013
|
106 |
S1 |
p. S5-
1 p.
|
artikel
|
| 124 |
SP-048: New Surgical Approaches on Thyroid Cancer in a Multidisciplinary Scheme
|
Andry, G.
|
|
2013
|
106 |
S1 |
p. S20-
1 p.
|
artikel
|
| 125 |
SP-049: Optimisation of Radio-Isotope Treatments
|
Leboulleux, S.
|
|
2013
|
106 |
S1 |
p. S20-
1 p.
|
artikel
|
| 126 |
SP-010: Particle Therapy and other New Techniques in Radiation Delivery
|
Langendijk, H.
|
|
2013
|
106 |
S1 |
p. S4-
1 p.
|
artikel
|
| 127 |
SP-033: Randomized Study of Darbepoetin Alfa as Modifier of Radiotherapy in Patients SCCHN. Final Outcome of the Dahanca 10 Trial
|
Overgaard, J.
|
|
2013
|
106 |
S1 |
p. S13-
1 p.
|
artikel
|
| 128 |
SP-034: RESULTS of the ARO 04-01 Trial of Concurrent 72 GY Hart/Cis-Platinum/5-FU vs. Hart/Mitomycin/5-FU in LAD H&N Cancer
|
Budach, V.
|
|
2013
|
106 |
S1 |
p. S13-
1 p.
|
artikel
|
| 129 |
SP-009: Sentinel Node Biopsy in Early Stage Oral Cancer
|
Stoeckli, S.
|
|
2013
|
106 |
S1 |
p. S3-
1 p.
|
artikel
|
| 130 |
SP-006 - SP-007: Extreme (PF+/-Cetuximab) and Spectrum (PF+/- Panitumumab): HPV Status and Outcome
|
Vermorken, J.
|
|
2013
|
106 |
S1 |
p. S2-S3
2 p.
|
artikel
|
| 131 |
SP-011: Targeted Agents: Cetuximab and Beyond
|
Licitra, L.
|
|
2013
|
106 |
S1 |
p. S4-
1 p.
|
artikel
|
| 132 |
SP-050: Tyrosine Kinase Inhibitors in Medullary and Other Thyroid Carcinoma
|
Schlumberger, M.
|
|
2013
|
106 |
S1 |
p. S20-
1 p.
|
artikel
|
| 133 |
SP-005: Update of 2 GORTEC Larynx Preservation Randomised Trials (GORTEC 2000-01 and TREMPLIN)
|
Pointreau, Y.
|
|
2013
|
106 |
S1 |
p. S2-
1 p.
|
artikel
|
| 134 |
SP-031: Update of R-TOG 0522. A Randomised Phase III Trial of Concurrent Accelerated Radiation and Cispltin Versus Concurrent Accelerated Radiation, Cisplatin and Cetuximab (C225) for State III and IV Head and Neck Carcinomas
|
Ang, K.K.
|
|
2013
|
106 |
S1 |
p. S12-
1 p.
|
artikel
|
| 135 |
SP-012: What is the Role of Induction Chemotherapy in Locally Advanced H&N Cancer in 2013?
|
Vermorken, J.
|
|
2013
|
106 |
S1 |
p. S4-
1 p.
|
artikel
|
| 136 |
SP-003: 10-Year Results of the Two EORTC Larynx Preservation Trials (EORTC 24851 and EORTC 24954)
|
Leemans, C.R.
|
|
2013
|
106 |
S1 |
p. S1-
1 p.
|
artikel
|
| 137 |
Title Page
|
|
|
2013
|
106 |
S1 |
p. iii-
1 p.
|
artikel
|
Tijdschrift beschrijving